Julia Challinor, RN, PhD, MS in Education and MS in Med Anthropology – Dr. Challinor serves as a consultant for multiple international projects in Africa, Asia and Latin America for childhood cancer and pediatric oncology nursing. She is currently the International Society for Paediatric Oncology (SIOP) Secretary General, and a Core Team member of the SIOP Global Mapping of Pediatric Oncology Services project. She serves on the US-based Association of Pediatric Oncology Nurses Spanish sub-Committee of the Global Outreach Committee that oversees the Spanish version of the Chemotherapy/Biotherapy nursing course in Latin America.
Dr. Challinor was the Educational Liaison for children with cancer and survivors at the University of California San Francisco from 1993-2003. During 1994-2006, as President of A Tomorrow for Children Foundation she worked in partnership with pediatric oncology centers associated with the Asociación de Hemato-Oncología Pediátrica de Centro America (AHOPCA), and collaborated with St Jude Children’s Research Hospital International Outreach Program, the Pediatric Oncology Group of Ontario (Canada) (POGO), and the Monza International School of Pediatric Hematology/Oncology (Italy) (MISPHO). Recently, she has been participating in pediatric oncology nursing initiatives in Ethiopia with The Aslan Project and Delhi, India, at the Rajiv Gandhi Cancer Institute.
Dr. Challinor participates in the WHO Global Childhood Initiative for Childhood Cancer (GICC). She attended the WHO (GICC) workshop in Lima Peru in 2019 and collaborates in ongoing related nursing projects in the country and WHO GICC nursing efforts overall.
Patrick Loehrer, Sr. MD - is the Joseph W. and Jackie J. Cusick Professor in Oncology and Distinguished Professor of Indiana University. He is also the Director of the IUSCCC Center for Global Oncology and Health Equities. He has been an active clinical researcher and specialist in the treatment of a variety of cancers including testis, bladder, colon, pancreas and, most notably, thymic malignancies. His research on the drug, ifosfamide, led to its approval by the FDA. His research related to thymic cancers has been recognized with the Exceptional Service Award of the Foundation for Thymic Research. He is co-PI on a U54 grant studying the long-term impact of HPV in HIV infected and uninfected women in Kenya and Uganda.
Dr. Loehrer received his undergraduate degree in Mechanical Engineering from Purdue University and his medical degree from Rush Medical College. He completed his internship and residency at Rush Presbyterian St. Luke's Medical Center and a fellowship in Medical Oncology at Indiana University. In 1983, he joined the faculty of the Indiana University School of Medicine. Dr. Loehrer is director emeritus of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, an NCI-designated Cancer Center and led the efforts to achieve comprehensive status in 2019.
Dr. Loehrer has received numerous awards including the Special Recognition Award and the inaugural, Allen S. Lichter Visionary Leader Award from the American Society of Clinical Oncology. From Purdue University, he has received the Outstanding Mechanical Engineering Award and the Distinguished Engineering Alumni Award in 2015. He is the recipient of the President’s Medal for Excellence and the Bicentennial Medal from Indiana University. He has served on the Board of Directors for the American Board of Internal Medicine, American Society of Clinical Oncology and the American Association of Cancer Institutes. He is currently the Chair of the NCI Clinical Trials Advisory Committee.
Dr. Loehrer was the founding chair of the Hoosier Oncology Group (now Hoosier Cancer Research Network) for two decades, which has enrolled over 5,000 patients and conducted trials in 20 countries around the world. Dr. Loehrer has served on the boards of the ECOG Foundation, the American Society of Clinical Oncology, and the American Board of Internal Medicine. He serves on the Advisory Committee for the Indiana University Center for Global Health. Dr. Loehrer is also the founding director of the Academic Model for Providing Access to Healthcare (AMPATH)-Oncology Program for over the past decade, which now sees over 8,000 cancer patients a year and screens over 1,500 women for cervical and breast cancers a month in western Kenya.
Dan Milner, MD, MSc, FASCP – Dr. Milner is the Chief Medical Officer and director for the Center for Global Health at the American Society for Clinical Pathology (ASPC). Dr. Milner leads all ASCP activities with the President’s Emergency Relief for AIDS relief (PEPFAR) and the Cancer Diagnosis and Treatment in Africa Initiative.
Aggrey Semeere, MD – Dr. Semeere is a Ugandan trained physician and researcher based at the Infectious Diseases Institute (IDI), Makerere University College of Health Sciences (MUCHS) in Kampala, Uganda. He has specialist training in Internal Medicine with advanced training in Epidemiology and Implementation Science from the University of California, San Francisco (UCSF). His research incorporates epidemiology, prevention and early detection of cancer and cardiovascular disease mostly among HIV-infected adults. He has led and continues to lead a number of research projects with collaborations not only within Uganda, but in Kenya, Rwanda, Malawi, Nigeria, Tanzania, Botswana and various US based universities. He also teaches and mentors Epidemiology Methods, Implementation Science and Internal Medicine at MUCHS and UCSF.
Larry Shulman, MD – Dr. Shulman is Professor of Medicine at the Perelman School of Medicine and Associate Director for Special Projects at the Abramson Cancer Center at the University of Pennsylvania. In this role, Dr. Shulman helps lead the Cancer Quality Program and the strategic development of cancer services across 6 Penn hospitals and their associated ambulatory cancer centers. He is Director of the Center for Global Cancer Medicine at the Abramson Cancer Center and serves as Senior Oncology Advisor to the non-profit organization Partners In Health (PIH). The PIH mission includes the establishment of national cancer treatment programs with the Ministries of Health in Rwanda and Haiti, programs for which he plays a seminal leadership role. He also sits on the Vice Chancellor's Advisory Council for Rwanda's University for Global Health Equity. Through the Botswana-UPenn Partnership, Dr. Shulman helps lead the development of the national oncology program in Botswana. Dr Shulman is a member of the National Cancer Policy Forum of the National Academies of Science, Engineering, and Medicine, and former Chair of the Commission on Cancer.
